Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol

被引:0
|
作者
Kirsten J. Langdon
Anthony E. Hitch
Alexandra B. Collins
Curt G. Beckwith
Sara Becker
Karen Tashima
Josiah D. Rich
机构
[1] Rhode Island Hospital,Department of Psychiatry
[2] Alpert Medical School of Brown University,Department of Psychiatry and Human Behavior
[3] Brown-Lifespan Center for Digital Health,Department of Psychology
[4] University of Cincinnati,Department of Epidemiology
[5] Brown University School of Public Health,Center for Dissemination and Implementation Science
[6] Northwestern University,Department of Medicine, Division of Infectious Diseases
[7] Brown University and The Miriam and Rhode Island Hospitals,undefined
关键词
Opioid use disorder; HIV; Medications for opioid use disorder; Long-acting injectable medication; Antiretroviral therapy; Antiviral resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [11] Cannabis Use, Medication Management and Adherence Among Persons Living with HIV
    Denise C. Vidot
    Brenda Lerner
    Raul Gonzalez
    AIDS and Behavior, 2017, 21 : 2005 - 2013
  • [12] Cannabis Use, Medication Management and Adherence Among Persons Living with HIV
    Vidot, Denise C.
    Lerner, Brenda
    Gonzalez, Raul
    AIDS AND BEHAVIOR, 2017, 21 (07) : 2005 - 2013
  • [13] Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont
    Rey, Catalina N.
    Badger, Gary J.
    Melbostad, Heidi S.
    Wachtel, Deborah
    Sigmon, Stacey C.
    MacAfee, Lauren K.
    Dougherty, Anne K.
    Heil, Sarah H.
    CONTRACEPTION, 2020, 101 (05) : 333 - 337
  • [14] Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder
    Montgomery, Catharine
    Abbasi, Yasir
    De Silva, Devon
    Gittins, Rosalind
    Jones, Andrew
    Van Hout, Marie-Claire
    BMJ OPEN, 2025, 15 (02):
  • [15] Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder
    Matusiewicz, Alexis K.
    Melbostad, Heidi S.
    Heil, Sarah H.
    CONTRACEPTION, 2017, 96 (05) : 365 - 369
  • [16] Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV
    Simoni, Jane M.
    Beima-Sofie, Kristin
    Mohamed, Zahra H.
    Christodoulou, Joan
    Tapia, Kenneth
    Graham, Susan M.
    Ho, Rodney
    Collier, Ann C.
    AIDS PATIENT CARE AND STDS, 2019, 33 (03) : 104 - 111
  • [17] Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study
    Parkin, Stephen
    Neale, Joanne
    Strang, John
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2023, 122
  • [18] Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder
    Greene, Mallik
    Yan, Tingjian
    Chang, Eunice
    Hartry, Ann
    Touya, Maelys
    Broder, Michael S.
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 127 - 134
  • [19] DISTRIBUTION AND DETERMINANTS OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC MEDICATION USE AMONG OLDER ADULTS
    Lohman, Matthew
    Verma, Mansi
    Jones, Paige
    Scott, Victoria
    Fields, Eve
    INNOVATION IN AGING, 2024, 8 : 161 - 161
  • [20] A Conjoint Analysis of the Acceptability of Targeted Long-Acting Injectable Antiretroviral Therapy Among Persons Living with HIV in the U.S.
    Jane M. Simoni
    Kenneth Tapia
    Sung-Jae Lee
    Susan M. Graham
    Kristin Beima-Sofie
    Zahra H. Mohamed
    Joan Christodoulou
    Rodney Ho
    Ann C. Collier
    AIDS and Behavior, 2020, 24 : 1226 - 1236